6-K 1 zk1517152.htm 6-K zk1517152.htm
UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2015
 
Commission File Number: 001-36187

EVOGENE LTD.
  (Translation of Registrant’s Name into English)
 
13 Gad Feinstein Street
Park Rehovot P.O.B 2100
Rehovot 7612002 Israel
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F x   Form 40-F o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
 
 
 
 
 
CONTENTS
 
Attached hereto and incorporated by reference herein is the following exhibit:
 
99.1
Press Release: Evogene Announces Successful Completion of First Computational Discovery of Novel Microbial Genes for Insect Control.
 
 
2
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
Date: August 4, 2015
  
EVOGENE  LTD.
(Registrant)
 
By: /s/ Sigal Fattal
——————————————
Sigal Fattal
Chief Financial Officer

 
3
 
 
EXHIBIT INDEX

EXHIBIT NO.
DESCRIPTION
 
99.1
Press Release: Evogene Announces Successful Completion of First Computational Discovery of Novel Microbial Genes for Insect Control.

4